The shift in principal investigator occurred as part of the IND that was purchased from U of M. TSOI has defaulted on payments for that IND. That P3 has not gone anywhere and is highly unlikely to at any point. Hence, TSOI claimed to have filed for to Initiate a "NEW" Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) on 4/20/23. Nearly 4 months later has anyone heard anything about that? How typical is that? But they got cells!!!